RS 2135

Known as: RS-2135 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-1996
01219911996

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
We investigated the way in which Na+ channel blocking class I antiarrhythmic drugs, lidocaine (30 mu M), flecainide (30 mu M… (More)
Is this relevant?
1994
1994
To assess the ability of RS-2135, a novel class I antiarrhythmic agent to suppress ischemia-induced ventricular arrhythmias, we… (More)
Is this relevant?
1993
1993
The use-dependent decrease in maximum upstroke velocity (Vmax) caused by RS-2135, a new antiarrhythmic compound was analyzed in… (More)
Is this relevant?
1993
1993
1. The novel K+ channel opener, Y-26763 induced outward K+ currents in voltage-clamped follicle-enclosed Xenopus oocytes in a… (More)
Is this relevant?
1992
1992
RS-2135 is the (+) isomer of a novel, fused carbazol derivative. The agent, when administered orally, shows long-lasting… (More)
Is this relevant?
1992
1992
A series of 12-aminotetrahydroisoquinocarbazoles and related compounds were synthesized using an intramolecular Diels-Alder… (More)
Is this relevant?
1991
1991
Antiarrhythmic and cardiovascular profiles of a fused indole compound, (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b… (More)
Is this relevant?